33 results on '"Bizjajeva, Svetlana"'
Search Results
2. MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
3. Antithetic sampling for sequential Monte Carlo methods with application to state-space models
4. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
5. Congenital cataract screening in maternity wards is effective: evaluation of the Paediatric Cataract Register of Sweden
6. Indications for hip and knee replacement in Sweden
7. Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial
8. Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents
9. 2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age
10. MF59-Adjuvanted Seasonal Inactivated Influenza Vaccine: Well Tolerated and Highly Immunogenic in Young Children – Cumulative Clinical Experience
11. Additional file 2: Figure S1. of Paediatric Fabry disease: prognostic significance of ocular changes for disease severity
12. Paediatric Fabry disease : prognostic significance of ocular changes for disease severity
13. Additional file 1: Table S1. of Paediatric Fabry disease: prognostic significance of ocular changes for disease severity
14. MF59-Adjuvanted Seasonal Inactivated Influenza Vaccine: Well Tolerated and Highly Immunogenic in Young Children With Underlying Medical Conditions
15. A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation
16. Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation: Data from the Fabry Outcome Survey
17. Paediatric Fabry disease: prognostic significance of ocular changes for disease severity
18. Fabry in the older patient: Clinical consequences and possibilities for treatment
19. Clinical characteristics and demographics in patients 50years and older in the Fabry Outcome Survey (FOS)
20. Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events
21. A Fabry Outcome Survey (FOS) analysis of cardiac biomarkers and left ventricular hypertrophy in Taiwanese patients with the Chinese hotspot IVS4+919G>A mutation or classical Fabry mutations
22. Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy: A 10-year Fabry Outcome Survey analysis
23. Antithetic sampling for sequential Monte Carlo methods with application to state-space models
24. Knee arthroplasty in Denmark, Norway and Sweden
25. Sequential Monte Carlo Methods with Applications to Positioning and Tracking in Wireless Networks
26. A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation.
27. Congenital cataract screening in maternity wards is effective: evaluation of the Paediatric Cataract Register of Sweden
28. Indications for hip and knee replacement in Sweden
29. Knee arthroplasty in Denmark, Norway and Sweden
30. Mobile Positioning in MIMO System Using Particle Filtering
31. A Fabry Outcome Survey (FOS) analysis of cardiac biomarkers and left ventricular hypertrophy in Taiwanese patients with the Chinese hotspot IVS4 + 919G > A mutation or classical Fabry mutations.
32. Clinical characteristics and demographics in patients 50 years and older in the Fabry Outcome Survey (FOS).
33. [Eye screening in the maternity ward is efficient. Time for more distinct Swedish guidelines, according to prospective registry study].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.